Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Wellington children part of global vaccine research

Mothers and infants in the Wellington region are set to play an important role in global research to develop a universal flu vaccine.

ESR researchers are currently seeking pregnant women in Wellington to participate in the study to see how their child’s first exposure to the flu virus, influences their immune response throughout life.

The “WellKiwis” study aims to monitor flu and flu-like illness in 600 Wellington children for seven years through to March 2026.

Mothers and infants in the Wellington region will be joining groups in Nicaragua, and United States as part of an international collaboration being led by St Jude Children’s Research Hospital in Memphis.

ESR’s National Influenza Centre has been selected by the US National Institutes of Health for the US$3.2 million research project.

Principal Investigator, ESR’s Dr Sue Huang says the purpose of WellKiwis is to provide information to enable scientists and researchers to develop more effective and longer lasting vaccines to prevent flu for our future populations.

“We have seen increasing scientific reports showing how the human immune system is primed by its first exposure to flu in childhood. Unravelling the codes of this childhood imprinting may allow us to identify those imprints that ‘memorise’ certain flu viruses which change little and differ little between flu strains.”

Flu, unlike a common cold, is a serious illness affecting hundreds and thousands of people globally. In New Zealand, young children and the elderly are particularly vulnerable to its infection.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Dr Sue Huang says this information gathered in the study may help in the development of a universal vaccine.

“We could produce broadly reactive and longer lasting antibodies to protect a population against multiple flu strains (including new pandemic strains). This would mean a vaccine shot once every three to five years rather than annually.”

WellKiwis study staff will monitor a child’s flu-like illness for seven years through regular surveys.

Over the course of the study, a once-only baseline cord blood sample from the birth mother and an annual blood sample will be collected from each child.

Additional samples will be needed if a child has a flu virus infection or flu vaccine.

“This study is important, as it adds to the scientific knowledge about the body’s immune responses to the flu in early childhood” says Dr Huang.

ESR aims to recruit 200 babies per year, for the next three years.


© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.